Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WG101
- Development stage
- Unknown
- Lead developer
- Wingor Biotechnology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
WG101 is an allogeneic stem cell therapy composed of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), developed by Shenzhen Wingor Biotechnology. The drug is primarily designed to treat degenerative and chronic neurological conditions, with its most advanced clinical program targeting ischemic stroke. WG101 has received Investigational New Drug (IND) acceptance from the China National Medical Products Administration (NMPA) and is currently undergoing Phase I/IIa clinical trials. These studies are being conducted at specialized institutions, including Beijing Tiantan Hospital and Shenzhen Second People's Hospital, to evaluate the safety, tolerability, and potential of the cells to promote tissue repair and immunomodulation in patients.
- Other names
- Human Umbilical Cord Mesenchymal Stem Cell Injection人脐带间充质干细胞注射液
Beyond the preview
Go deeper on WG101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WG101.